Jeffrey Needham - Perrigo Company President

PRGO -- USA Stock  

USD 56.70  0.74  1.32%

  President
Mr. Jeffrey R. Needham serves as Executive Vice President, President Consumer Healthcare Americas of the Company. He served as Senior Vice President of Commercial Business Development for Consumer Healthcare from March 2005 through October 2009. Previously, he served as Senior Vice President of International from November 2004 to March 2005. He served as Managing Director of Perrigos U.K. operations from May 2002 to November 2004 and as Vice President of Marketing from 1993 to 2002.
Age: 61  President Since 2009      
353 1 709 4000  http://www.perrigo.com

Jeffrey Needham Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 2.34 % which means that it generated profit of $2.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 1.49 % meaning that it created $1.49 on every $100 dollars invested by stockholders.
The company currently holds 3.62B in liabilities with Debt to Equity (D/E) ratio of 63.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 1.88 which is within standard range for the sector.

Similar Executives

Showing few of many executives

PRESIDENT Since

Michael AbermanRegeneron Pharmaceuticals
2015
Christopher FenimoreRegeneron Pharmaceuticals
2017
Paul SilvaVertex Pharmaceuticals Incorpor
2019
Umang VohraDr Reddys Laboratories Ltd
2013
Saumen ChakrabortyDr Reddys Laboratories Ltd
2018
Joyce LeeZoetis
2012
Daniel PlewRegeneron Pharmaceuticals
2016
Glenn DavidZoetis
2016
Roxanne LaganoZoetis
2015
Samiran DasDr Reddys Laboratories Ltd
2016
Ganadhish KamatDr Reddys Laboratories Ltd
2016
Raghav ChariDr Reddys Laboratories Ltd
2013
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
John GrayVertex Pharmaceuticals Incorpor
2019
Cartikeya ReddyDr Reddys Laboratories Ltd
2016
Charles MilsteinVertex Pharmaceuticals Incorpor
2017
Clinton LewisZoetis
2018
Heidi ChenZoetis
2012
K RaoDr Reddys Laboratories Ltd
2016
George YancopoulosRegeneron Pharmaceuticals
2016
Peter PowchikRegeneron Pharmaceuticals
2006

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Currently Active Assets on Macroaxis

MSFT   
Purchased over 20 shares of
1 hour ago
Traded for 135.34
VMW   
Purchased a lot of shares of
1 hour ago
Traded for 155.87
GM   
Purchased over 70 shares of
1 hour ago
Traded for 35.56
V   
Purchased few shares of
1 hour ago
Traded for 174.95
CRM   
Purchased a lot of shares of
1 hour ago
Traded for 153.01
Additionally take a look at Your Equity Center. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.
Search macroaxis.com